Zealand Pharma A/S
2 products tracked · names used in filings: Zealand Pharma A/S
Upcoming milestones
Mon 23 Nov 2026🇪🇺 Expected EC decisionestimatein 9 days
Zeydovio (glepaglutide): expected EC decision
Estimated as CHMP opinion (2026-09-17) + 67 days, the standard Commission decision period. Not an official date. · Zealand Pharma A/S · source
Recent milestones
Thu 17 Sep 2026🇪🇺 CHMP positive opinion
Zeydovio (glepaglutide): CHMP positive opinion
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Zeydovio glepaglutide | Opinion | |
| 🇪🇺 | Zegalogue dasiglucagon | Authorised | 2024-07-24 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.